You just read:

Neurocrine Announces INGREZZA® (valbenazine) Capsules Pharmacokinetic Profile and Long-Term Data to be Presented at the 2017 American Psychiatric Association Annual Meeting

News provided by

Neurocrine Biosciences, Inc.

May 18, 2017, 16:05 ET